Cryoport (NASDAQ:CYRX) Posts Earnings Results, Misses Estimates By $0.09 EPS

Cryoport (NASDAQ:CYRX - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.42) EPS for the quarter, missing the consensus estimate of ($0.33) by ($0.09), Zacks reports. Cryoport had a negative net margin of 70.08% and a negative return on equity of 13.35%. The business had revenue of $59.53 million during the quarter, compared to analyst estimates of $58.71 million. During the same period last year, the company earned ($0.29) EPS. Cryoport updated its FY 2025 guidance to EPS.

Cryoport Trading Down 6.5 %

Shares of CYRX stock traded down $0.43 on Friday, hitting $6.23. The stock had a trading volume of 386,284 shares, compared to its average volume of 315,400. The company's 50 day moving average price is $7.28 and its 200-day moving average price is $7.61. The company has a debt-to-equity ratio of 0.48, a current ratio of 5.70 and a quick ratio of 5.32. Cryoport has a 1 year low of $4.58 and a 1 year high of $20.10. The firm has a market capitalization of $307.96 million, a P/E ratio of -1.84 and a beta of 1.59.

Analysts Set New Price Targets

Several equities analysts have recently commented on the company. Roth Mkm decreased their price target on Cryoport from $18.00 to $15.00 and set a "buy" rating on the stock in a research note on Friday, November 8th. Guggenheim assumed coverage on Cryoport in a research note on Thursday, December 19th. They issued a "buy" rating and a $11.00 price target on the stock. Finally, Needham & Company LLC reaffirmed a "buy" rating and issued a $11.00 price target on shares of Cryoport in a research note on Wednesday. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, Cryoport has an average rating of "Moderate Buy" and a consensus price target of $12.29.

Remove Ads

About Cryoport

Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.